Medtronic's Kappa 700 pacer to offer ease-of-use advantages over recently introduced Kappa 400.
This article was originally published in The Gray Sheet
MEDTRONIC KAPPA 700 PACEMAKER PHYSICIAN EASE OF USE COULD BE KEY SELLING POINT to doctors unfamiliar and/or uncomfortable with high-tech features offered by next-generation pacemakers, Mario Talejic, MD, University of Montreal, and a clinical investigator of the Kappa 700 suggested. Speaking at a Feb. 3 session of the Piper Jaffray medical device conference in New York City, Talejic said that the Kappa 700 also is intended to streamline implant procedures and reduce the amount of time needed for patient follow-up.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.